Medulloblastoma – V9: 2023+
| Primary Site | Histology | Year of Diagnosis |
|---|---|---|
| C700-C729 | 9362, 9470-9472, 9474-9478, 9501-9504, 9508 | 2023-9998, 9999 |
| C700-C722, C724-C729 | 9473 | 2023-9998, 9999 |
| C753 | 9362 | 2023-9998, 9999 |
Notes
C700-C729: 9362, 9470-9472, 9474-9478, 9501-9504, 9508 C700-C722, C724-C729: 9473 C753: 9362 C700 Cerebral meninges C701 Spinal meninges C709 Meninges, NOS C710 Cerebrum C711 Frontal lobe C712 Temporal lobe C713 Parietal lobe C714 Occipital lobe C715 Ventricle, NOS C716 Cerebellum, NOS C717 Brain stem C718 Overlapping lesion of brain C719 Brain, NOS C720 Spinal cord C721 Cauda equina C722 Olfactory nerve C723 Optic nerve C724 Acoustic nerve C725 Cranial nerve, NOS C728 Overlapping lesion of brain and central nervous system C729 Nervous system, NOS C753 Pineal Gland (9362 only) **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Brain and Spinal Cord, from the AJCC Cancer Staging System Version 9 (2022). Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** This is a new schema for cases diagnosed 2023+. For cases diagnosed prior to 2023, see the following schemas * Brain (C700, C710-C719) * CNS Other (C701, C709, C720-C721, C728-C729) * Intracranial Gland (C753)Data Items
| Name | Default Value | Used in Derivation | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | Yes |
NAACCR #390
dateOfDiagnosis |
None | ||
| Primary Site | Yes |
NAACCR #400
primarySite |
None | ||
| Histology | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | ||
| Behavior | Yes |
NAACCR #523
behaviorCodeIcdO3 |
None | ||
| Tumor Size Clinical | No |
NAACCR #752
tumorSizeClinical |
None | ||
| Tumor Size Pathological | No |
NAACCR #754
tumorSizePathologic |
None | ||
| Tumor Size Summary | 999 | No |
NAACCR #756
tumorSizeSummary |
None | |
| Regional Nodes Positive | 99 | No |
NAACCR #820
regionalNodesPositive |
None | |
| Regional Nodes Examined | 99 | No |
NAACCR #830
regionalNodesExamined |
None | |
| LVI | 9 | No |
NAACCR #1182
lymphVascularInvasion |
None | |
| EOD Primary Tumor | 999 | Yes |
NAACCR #772
eodPrimaryTumor |
None | |
| EOD Regional Nodes | 888 | Yes |
NAACCR #774
eodRegionalNodes |
None | |
| EOD Mets | 00 | Yes |
NAACCR #776
eodMets |
None | |
| SS2018 | No |
NAACCR #764
summaryStage2018 |
None | ||
| Grade Clinical | 9 | No |
NAACCR #3843
gradeClinical |
CCCR/Canada COC NPCR SEER |
SSDI |
| Grade Pathological | 9 | No |
NAACCR #3844
gradePathological |
CCCR/Canada COC NPCR SEER |
SSDI |
| Grade Post Therapy Clin (yc) | No |
NAACCR #1068
gradePostTherapyClin |
COC NPCR SEER |
SSDI | |
| Grade Post Therapy Path (yp) | No |
NAACCR #3845
gradePostTherapy |
CCCR/Canada COC NPCR SEER |
SSDI | |
| Brain Molecular Markers | 88 | No |
NAACCR #3816
brainMolecularMarkers |
NPCR SEER |
SSDI |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Schema ID | 09724 |
NAACCR #3800
schemaId |
None | |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Summary Stage 2018 | 9 |
NAACCR #762
derivedSummaryStage2018 |
None |